Acute Respiratory Distress Syndrome Pipeline Report 2024: Insight Encompasses Over 50 Companies and Drug Profiles [Yahoo! Finance]
Windtree Therapeutics, Inc. (WINT)
Last windtree therapeutics, inc. earnings: 8/21 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
windtreetx.investorroom.com
Company Research
Source: Yahoo! Finance
Understanding the rapid developments and the expansive growth of therapeutic candidates in Acute Respiratory Distress Syndrome (ARDS), a critical lung condition marked by fluid leakage and difficulty in breathing, is essential. A new comprehensive research publication has been added to our website providing insights into the thriving ARDS pipeline landscape up to the year 2024. An extensive range of over 50 companies is engaged in driving innovation within the space, with more than 50 pipeline drugs at various stages of development. The global coverage of the report ensures that stakeholders can gauge activities from diverse geographies, offering a well-rounded perspective of the ARDS sector. This detailed report offers deep analysis by product type, disease progression, route of administration, and molecule type. It serves as a critical tool for healthcare sector stakeholders, biopharmaceutical companies, researchers, and medical professionals looking to stay abreast of the rapi
Show less
Read more
Impact Snapshot
Event Time:
WINT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WINT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WINT alerts
High impacting Windtree Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
WINT
News
- Windtree Therapeutics Announces Reverse Stock SplitGlobeNewswire
- Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates [Yahoo! Finance]Yahoo! Finance
- Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesGlobeNewswire
- Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing [Yahoo! Finance]Yahoo! Finance
- Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingGlobeNewswire
WINT
Sec Filings
- 4/23/24 - Form 8-K
- 4/17/24 - Form S-3/A
- 4/17/24 - Form 8-K
- WINT's page on the SEC website